(3S,6R,9S,12R,15S,18R)-3-[(2S)-2-Butanyl]-6,9,12,15,18-pentaisopropyl-4,10,16-trimethyl-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone(CAS: 19914-20-6)

The compound is a cyclic, heterocyclic compound with a complex molecular structure. It has a crystalline form with a molecular weight of approximately 684.6 g/mol. The compound is slightly soluble in organic solvents like dichloromethane and acetonitrile. Chemically, it is stable under normal conditions but reacts with strong oxidizers. It exhibits limited reactivity, especially in basic conditions.

This compound is typically synthesized via a multistep process involving ring-closing metathesis (RCM) followed by selective functional group transformations. Common starting materials include cyclic diols and alkynes. The reaction requires a Grubbs catalyst and is carried out at elevated temperatures under inert conditions to achieve high yields and good selectivity.

This compound is primarily used in the pharmaceutical industry for the development of complex organic molecules. It also finds applications in the field of polymer science for the synthesis of high-performance polymers. Additionally, it is utilized in the production of sensors and electronic components due to its unique molecular structure.

When handling this compound, it is essential to wear appropriate personal protective equipment (PPE) such as gloves, goggles, and a lab coat. Ensure the compound is stored in a well-ventilated area and avoid inhaling vapors. Work under a fume hood when performing synthesis or handling. Follow standard laboratory safety protocols, and in case of a spill, immediately clean up according to the safety data sheet (SDS).